1. Home
  2. XRTX vs IPDN Comparison

XRTX vs IPDN Comparison

Compare XRTX & IPDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XRTX
  • IPDN
  • Stock Information
  • Founded
  • XRTX 2011
  • IPDN 2003
  • Country
  • XRTX Canada
  • IPDN United States
  • Employees
  • XRTX N/A
  • IPDN N/A
  • Industry
  • XRTX Pharmaceuticals and Biotechnology
  • IPDN EDP Services
  • Sector
  • XRTX Health Care
  • IPDN Technology
  • Exchange
  • XRTX Nasdaq
  • IPDN Nasdaq
  • Market Cap
  • XRTX 4.4M
  • IPDN 5.2M
  • IPO Year
  • XRTX N/A
  • IPDN 2013
  • Fundamental
  • Price
  • XRTX $0.67
  • IPDN $3.48
  • Analyst Decision
  • XRTX
  • IPDN
  • Analyst Count
  • XRTX 0
  • IPDN 0
  • Target Price
  • XRTX N/A
  • IPDN N/A
  • AVG Volume (30 Days)
  • XRTX 6.0M
  • IPDN 198.1K
  • Earning Date
  • XRTX 11-14-2025
  • IPDN 11-13-2025
  • Dividend Yield
  • XRTX N/A
  • IPDN N/A
  • EPS Growth
  • XRTX N/A
  • IPDN N/A
  • EPS
  • XRTX N/A
  • IPDN N/A
  • Revenue
  • XRTX N/A
  • IPDN $6,459,379.00
  • Revenue This Year
  • XRTX N/A
  • IPDN N/A
  • Revenue Next Year
  • XRTX N/A
  • IPDN N/A
  • P/E Ratio
  • XRTX N/A
  • IPDN N/A
  • Revenue Growth
  • XRTX N/A
  • IPDN N/A
  • 52 Week Low
  • XRTX $0.63
  • IPDN $0.97
  • 52 Week High
  • XRTX $1.79
  • IPDN $12.39
  • Technical
  • Relative Strength Index (RSI)
  • XRTX 40.10
  • IPDN 48.37
  • Support Level
  • XRTX $0.63
  • IPDN $3.30
  • Resistance Level
  • XRTX $0.78
  • IPDN $3.83
  • Average True Range (ATR)
  • XRTX 0.09
  • IPDN 0.39
  • MACD
  • XRTX -0.03
  • IPDN -0.04
  • Stochastic Oscillator
  • XRTX 5.13
  • IPDN 39.23

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

About IPDN Professional Diversity Network Inc.

Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the TalentAlly Network segment, which maintains and operates job board software and hosts career fairs; the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization; the RemoteMore segment; and Corporate Overhead. The company generates majority of its revenue from TalentAlly Network Segment.

Share on Social Networks: